Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hull

Showing results (581-590 of 699) with videos related to

Pageof 70
Sort By:
Thrombosis and Haemostasis|May 12, 2005
Fatal vascular outcomes following major orthopedic surgeryOla E Dahl, Joseph A Caprini, Clifford W Colwell, et al.
The Bone & Joint Journal|November 2, 2019
Knee Fix or Replace Trial (KFORT): a randomized controlled feasibility studyPeter D Hull, Daud T S Chou, Sophie Lewis, et al.
Ultrasound Quarterly|August 18, 2015
Placental Sonolucencies in the First Trimester: Incidence and Clinical SignificanceRandall L Baldassarre, Michael Gabe, Dolores H Pretorius, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 12, 2022
Lung transplantation for chronic obstructive pulmonary disease: A call to modify the lung allocation score to decrease waitlist mortalityTravis D Hull, Gregory A Leya, Andrea L Axtell, et al.
Circulation|June 20, 2007
Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): the ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) studyGiancarlo Agnelli, Alexander Gallus, Samuel Z Goldhaber, et al.
Journal of Thrombosis and Haemostasis : JTH|August 9, 2019
Net-clinical benefit of extended prophylaxis of venous thromboembolism with betrixaban in medically ill patients aged 80 or moreWalter Ageno, Renato D Lopes, Megan K Yee, et al.
American Journal of Obstetrics and Gynecology|July 27, 2012
Preoperative intravascular balloon catheters and surgical outcomes in pregnancies complicated by placenta accreta: a management paradoxJerasimos Ballas, Andrew D Hull, Cheryl Saenz, et al.
Journal of Affective Disorders|July 9, 2022
At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trialThomas D Hull, Matteo Malgaroli, Adam Gazzaley, et al.
British Journal of Cancer|July 25, 2013
Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United KingdomD H Palmer, S A Hussain, A J Smith, et al.
American Journal of Hematology|September 26, 2018
Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trialGerald Chi, C Michael Gibson, Yuyin Liu, et al.
Pageof 70

Showing results (581-590 of 699) with videos related to

Sort By:
Pageof 70
Thrombosis and Haemostasis|May 12, 2005
Fatal vascular outcomes following major orthopedic surgeryOla E Dahl, Joseph A Caprini, Clifford W Colwell, et al.
The Bone & Joint Journal|November 2, 2019
Knee Fix or Replace Trial (KFORT): a randomized controlled feasibility studyPeter D Hull, Daud T S Chou, Sophie Lewis, et al.
Ultrasound Quarterly|August 18, 2015
Placental Sonolucencies in the First Trimester: Incidence and Clinical SignificanceRandall L Baldassarre, Michael Gabe, Dolores H Pretorius, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 12, 2022
Lung transplantation for chronic obstructive pulmonary disease: A call to modify the lung allocation score to decrease waitlist mortalityTravis D Hull, Gregory A Leya, Andrea L Axtell, et al.
Circulation|June 20, 2007
Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): the ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) studyGiancarlo Agnelli, Alexander Gallus, Samuel Z Goldhaber, et al.
Journal of Thrombosis and Haemostasis : JTH|August 9, 2019
Net-clinical benefit of extended prophylaxis of venous thromboembolism with betrixaban in medically ill patients aged 80 or moreWalter Ageno, Renato D Lopes, Megan K Yee, et al.
American Journal of Obstetrics and Gynecology|July 27, 2012
Preoperative intravascular balloon catheters and surgical outcomes in pregnancies complicated by placenta accreta: a management paradoxJerasimos Ballas, Andrew D Hull, Cheryl Saenz, et al.
Journal of Affective Disorders|July 9, 2022
At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trialThomas D Hull, Matteo Malgaroli, Adam Gazzaley, et al.
British Journal of Cancer|July 25, 2013
Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United KingdomD H Palmer, S A Hussain, A J Smith, et al.
American Journal of Hematology|September 26, 2018
Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trialGerald Chi, C Michael Gibson, Yuyin Liu, et al.
Pageof 70